Boryung Pharmaceutical Co. Ltd. | |
Stock Exchange | Korea Exchange Commodity Market |
EPS |
KRW582.15 |
Market Cap |
KRW493.97 B |
Shares Outstanding |
44.2 M |
Public Float |
18.53 M |
Address |
Boryung Building Seoul SL 03127 Korea, Republic Of |
Employees | - |
Website | http://www.boryung.co.kr |
Updated | 07/08/2019 |
Boryung Pharmaceutical Co., Ltd. engages in the manufacture of of drug products. Its main products include Kanarb, Dukarb, Tuvero, TODULA, BESTO, and gelfosM. Its products include cardiovascular, antibiotics, anticancer, amino acid, cosmetics, gastrointestinal, and API. |